Q4 2025 · 13F-HR
BML Capital Management, LLCholdings as filed
Filed 2026-02-03 · accession 0001754960-26-000146
$115.7M
Reported value
16
Positions
2025-12-31
Period end
The Brief · BML Capital Management, LLC · Q4 2025
AI · grounded in 13F
BML Capital Management, LLC closed its position in Adverum Biotechnologies Inc AVU0, reducing exposure by $13.85M. The fund established a new position in Carmax Inc KMX worth $5.99M and exited its holding in Alumis Inc ALMS for $4.83M. Other new entries include Carvana Co CVNA at $2.02M and Outset Med Inc OM at $2.02M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $42.9M | 37.1% | 14,250,000 | Common | NONE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $26.7M | 23.1% | 7,490,000 | Common | NONE |
| 68403P203 | ORMP | ORAMED PHARMACEUTICALS INC | $9.0M | 7.80% | 3,167,231 | Common | NONE |
| 45783C200 | TIL | INSTIL BIO INC | $7.1M | 6.14% | 645,600 | Common | NONE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $6.6M | 5.72% | 5,292,000 | Common | NONE |
| 143130102 | KMX | CARMAX INC | $6.0M | 5.18% | 155,000 | Common | NONE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $4.5M | 3.92% | 720,787 | Common | NONE |
| 87612E106 | TGT | TARGET CORP | $3.7M | 3.17% | 37,500 | Common | NONE |
| 146869102 | CVNA | CARVANA CO | $2.0M | 1.74% | 150 | PUT | NONE |
| 690145206 | OM | OUTSET MED INC | $2.0M | 1.74% | 543,180 | Common | NONE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $1.9M | 1.63% | 1,546,137 | Common | NONE |
| 45175G207 | IMA | IMAGENEBIO INC | $1.2M | 1.06% | 177,026 | Common | NONE |
| G23549101 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $1.2M | 1.00% | 408,887 | Common | NONE |
| 931142103 | WMT | WALMART INC | $492,450 | 0.43% | 335 | PUT | NONE |
| 88160R101 | TSLA | TESLA INC | $205,000 | 0.18% | 1,000 | PUT | NONE |
| 128058302 | LSTA | LISATA THERAPEUTICS INC | $136,427 | 0.12% | 73,348 | Common | NONE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.